Xin-Hu Yang

563 total citations
17 papers, 416 citations indexed

About

Xin-Hu Yang is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Xin-Hu Yang has authored 17 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 4 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Pharmacology. Recurrent topics in Xin-Hu Yang's work include Schizophrenia research and treatment (14 papers), Bipolar Disorder and Treatment (5 papers) and Electroconvulsive Therapy Studies (3 papers). Xin-Hu Yang is often cited by papers focused on Schizophrenia research and treatment (14 papers), Bipolar Disorder and Treatment (5 papers) and Electroconvulsive Therapy Studies (3 papers). Xin-Hu Yang collaborates with scholars based in Macao, China and Australia. Xin-Hu Yang's co-authors include Wei Zheng, Dong-Bin Cai, Gábor S. Ungvári, Yu‐Tao Xiang, Chee H. Ng, Yu-Ping Ning, Shi-Bin Wang, Qing-E Zhang, Norbert Müller and Christoph U. Correll and has published in prestigious journals such as Journal of Affective Disorders, Schizophrenia Research and Journal of Psychiatric Research.

In The Last Decade

Xin-Hu Yang

16 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin-Hu Yang Macao 12 223 138 67 52 50 17 416
Yu-Ping Ning China 13 201 0.9× 116 0.8× 61 0.9× 60 1.2× 25 0.5× 22 431
Nico van Beveren Netherlands 11 246 1.1× 239 1.7× 49 0.7× 85 1.6× 50 1.0× 25 535
Yousong Su China 13 146 0.7× 234 1.7× 53 0.8× 118 2.3× 60 1.2× 40 524
Jennifer L. Kruse United States 11 127 0.6× 213 1.5× 64 1.0× 32 0.6× 33 0.7× 21 423
Kun-Yu Tu Taiwan 8 106 0.5× 84 0.6× 35 0.5× 38 0.7× 15 0.3× 12 321
J. Hatzimanolis Greece 14 298 1.3× 93 0.7× 58 0.9× 38 0.7× 23 0.5× 41 527
Camila M. Santos Brazil 13 135 0.6× 76 0.6× 100 1.5× 65 1.3× 14 0.3× 16 376
Franz Hozer France 8 93 0.4× 84 0.6× 31 0.5× 42 0.8× 24 0.5× 14 286
İbrahim Fatih Karababa Türkiye 13 111 0.5× 90 0.7× 49 0.7× 77 1.5× 15 0.3× 22 412
Amy Harrington United States 10 149 0.7× 221 1.6× 28 0.4× 86 1.7× 51 1.0× 19 482

Countries citing papers authored by Xin-Hu Yang

Since Specialization
Citations

This map shows the geographic impact of Xin-Hu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin-Hu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin-Hu Yang more than expected).

Fields of papers citing papers by Xin-Hu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin-Hu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin-Hu Yang. The network helps show where Xin-Hu Yang may publish in the future.

Co-authorship network of co-authors of Xin-Hu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xin-Hu Yang. A scholar is included among the top collaborators of Xin-Hu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin-Hu Yang. Xin-Hu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
Zheng, Wei, Dong-Bin Cai, Xin-Hu Yang, et al.. (2020). Adjunctive Fluvoxamine for Schizophrenia: A Meta-analysis of Randomized Double-Blind, Placebo-Controlled Trials. Journal of Clinical Psychopharmacology. 40(4). 386–390. 6 indexed citations
4.
Zheng, Wei, Qing-E Zhang, Dong-Bin Cai, et al.. (2019). Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials. Schizophrenia Research. 209. 12–21. 28 indexed citations
5.
Zheng, Wei, Dong-Bin Cai, Xin-Hu Yang, et al.. (2019). Adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis. General Psychiatry. 32(5). e100091–e100091. 12 indexed citations
6.
Zheng, Wei, Xin-Hu Yang, Dong-Bin Cai, et al.. (2019). Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials. Pharmacopsychiatry. 53(1). 5–13. 2 indexed citations
7.
Zheng, Wei, Qing-E Zhang, Xin-Hu Yang, et al.. (2018). Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials. Schizophrenia Research. 206. 13–20. 33 indexed citations
8.
Zheng, Wei, Xiao-Hong Li, Dong-Bin Cai, et al.. (2018). Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials. Schizophrenia Research. 197. 288–293. 27 indexed citations
9.
Zheng, Wei, Qing-E Zhang, Dong-Bin Cai, et al.. (2018). Combination of Metformin and Lifestyle Intervention for Antipsychotic-Related Weight Gain: A Meta-Analysis of Randomized Controlled Trials. Pharmacopsychiatry. 52(1). 24–31. 27 indexed citations
10.
Zheng, Wei, Dong-Bin Cai, Xin-Hu Yang, et al.. (2018). Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials. Journal of Psychiatric Research. 103. 244–251. 21 indexed citations
11.
Wang, Gang, Wei Zheng, Shi-Bin Wang, et al.. (2018). ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials. Journal of Psychiatric Research. 105. 23–32. 61 indexed citations
12.
Zheng, Wei, Yu-Ping Ning, Dong-Bin Cai, et al.. (2017). Erythropoietin for Cognitive Deficits Associated with Schizophrenia, Bipolar Disorder, and Major Depression: A Systematic Review. Pharmacopsychiatry. 51(3). 100–104. 21 indexed citations
13.
Zheng, Wei, Xiao-Hong Li, Dong-Bin Cai, et al.. (2017). Adjunctive azapirone for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials. European Neuropsychopharmacology. 28(1). 149–158. 7 indexed citations
14.
Zheng, Wei, Shibin Wang, Gábor S. Ungvári, et al.. (2017). Amantadine for Antipsychotic-Related Weight Gain. Journal of Clinical Psychopharmacology. 37(3). 341–346. 11 indexed citations
15.
Zheng, Wei, Dong-Bin Cai, Xin-Hu Yang, et al.. (2017). Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials. Journal of Psychiatric Research. 92. 139–146. 66 indexed citations
16.
Zheng, Wei, Xin-Hu Yang, Dong-Bin Cai, et al.. (2017). Adjunctive metformin for antipsychotic-related hyperprolactinemia: A meta-analysis of randomized controlled trials. Journal of Psychopharmacology. 31(5). 625–631. 25 indexed citations
17.
Zheng, Wei, Shi-Bin Wang, Xin-Hu Yang, et al.. (2016). Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials. European Neuropsychopharmacology. 27(1). 8–18. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yu-Ping Ning Breakdown of academic impact, for papers by Nico van Beveren Breakdown of academic impact, for papers by Yousong Su Breakdown of academic impact, for papers by Jennifer L. Kruse Breakdown of academic impact, for papers by Kun-Yu Tu Breakdown of academic impact, for papers by J. Hatzimanolis Breakdown of academic impact, for papers by Camila M. Santos Breakdown of academic impact, for papers by Franz Hozer Breakdown of academic impact, for papers by İbrahim Fatih Karababa Breakdown of academic impact, for papers by Amy Harrington
Rankless by CCL
2026